INGEGERD E HELLSTROM

Summary

Affiliation: Pacific Northwest Research Institute
Country: USA

Publications

  1. ncbi CD3-mediated activation of tumor-reactive lymphocytes from patients with advanced cancer
    I Hellstrom
    Pacific Northwest Research Institute, 720 Broadway, and Swedish Hospital and Medical Center, Tumor Institute, 747 Broadway, Seattle, WA 98122, USA
    Proc Natl Acad Sci U S A 98:6783-8. 2001
  2. ncbi The HE4 (WFDC2) protein is a biomarker for ovarian carcinoma
    Ingegerd Hellstrom
    Pacific Northwest Research Institute, Seattle, Washington 98122, USA
    Cancer Res 63:3695-700. 2003

Detail Information

Publications2

  1. ncbi CD3-mediated activation of tumor-reactive lymphocytes from patients with advanced cancer
    I Hellstrom
    Pacific Northwest Research Institute, 720 Broadway, and Swedish Hospital and Medical Center, Tumor Institute, 747 Broadway, Seattle, WA 98122, USA
    Proc Natl Acad Sci U S A 98:6783-8. 2001
    ....
  2. ncbi The HE4 (WFDC2) protein is a biomarker for ovarian carcinoma
    Ingegerd Hellstrom
    Pacific Northwest Research Institute, Seattle, Washington 98122, USA
    Cancer Res 63:3695-700. 2003
    ..However, the HE4 assay may have an advantage over the CA125 assay in that it is less frequently positive in patients with nonmalignant disease...